Trump administration will fund new research on controversial psychedelic drug ibogaine
AI Summary
U.S. federal officials have announced funding for research into ibogaine, a controversial psychedelic drug promoted by some veterans and political figures. The initiative will investigate its potential medical applications.
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.